EGFR and breast carcinoma: This notion is also supported by our observation that all types of chimeric GE11-MrNV VLPs showed little binding to EGFR-negative MCF7 breast cancer cell line and no significant increase in the binding was observed when compared to the N-MrNV (Supplementary Fig. S1).